Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
Keith A. Johnson(Brigham and Women's Hospital), Jeremy Carmasin(Harvard University), Jacqueline Maye(Harvard University), Carl Sadowsky(Nova Southeastern University), Daniel Skovronsky, Eric M. Reiman(Banner Alzheimer’s Institute), Adam Fleisher(Banner Alzheimer’s Institute), Mark A. Mintun(Mallinckrodt (Ireland)), Christopher Gidicsin(Harvard University), Michel J. Pontecorvo, Ming‐Chi Lu(Tzu Chi University), Christopher M. Clark(University of Pennsylvania), Marwan N. Sabbagh(Cleveland Clinic), Alan Carpenter, P. Murali Doraiswamy(Duke University), R. Edward Coleman, Reisa A. Sperling(Brigham and Women's Hospital), Abhinay D. Joshi
Cited by 264
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease
|Journal of Neuroscience|2009|2.9k
Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
|Journal of Neuroscience|2005|2.1k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k